The Chinese medicine JC-001 enhances the chemosensitivity of Lewis lung tumors to cisplatin by modulating the immune response
Abstract Background JC-001 is a Chinese medicine that can modulate the immunity in Hepa 1-6 tumor-bearing mice, and we questioned whether JC-001 can serve as efficient adjuvant chemotherapy. We aimed to identify a novel approach for enhancing cis-diamminedichloroplatinum (II) (CDDP)-based chemothera...
Main Authors: | Meng-Hsien Chuang, Ming-Shiou Jan, Jinghua Tsai Chang, Fung-Jou Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | BMC Complementary and Alternative Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12906-017-1728-x |
Similar Items
-
RasGAP-derived peptide GAP159 enhances cisplatin-induced cytotoxicity and apoptosis in HCT116 cells
by: Hao Zhang, et al.
Published: (2014-04-01) -
The significance of MGMT protein detection in evaluation of osteosarcoma necrosis rate after cisplatin chemotherapy
by: Qiu Cui, et al.
Published: (2011-05-01) -
Study of a Molecular Promoter for Enhancing Cisplatin Cancer Chemotherapy
by: Nguyen, Jenny
Published: (2010) -
Study of a Molecular Promoter for Enhancing Cisplatin Cancer Chemotherapy
by: Nguyen, Jenny
Published: (2010) -
Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
by: Katie K. Crean-Tate, et al.
Published: (2021-04-01)